Randy A. Albrecht mainly focuses on Virology, Influenza A virus, Virus, Interferon and Antibody. His Virology research is multidisciplinary, relying on both Chromatin, RIG-I and Immunology. His research in Influenza A virus intersects with topics in Viral matrix protein, Interferon type I, Interferon regulatory factors, Ubiquitin ligase and Cell biology.
Many of his research projects under Virus are closely connected to H5N1 genetic structure and Population with H5N1 genetic structure and Population, tying the diverse disciplines of science together. His Interferon research incorporates elements of Chemokine, Cell, Transcriptome and Cytokine. Randy A. Albrecht combines subjects such as Naive B cell, Chemokine receptor and Antigen with his study of Antibody.
His primary areas of investigation include Virology, Virus, Influenza A virus, Immunology and Antibody. Randy A. Albrecht performs integrative study on Virology and Pandemic. His work on Viral replication as part of general Virus study is frequently linked to H5N1 genetic structure, bridging the gap between disciplines.
His studies in Influenza A virus integrate themes in fields like Transmission, Respiratory tract and Neuraminidase. His Immunology research focuses on subjects like Cytotoxic T cell, which are linked to CD8. Randy A. Albrecht works mostly in the field of Antibody, limiting it down to topics relating to Antigen and, in certain cases, CXCR3, as a part of the same area of interest.
His main research concerns Virology, Virus, Influenza A virus, Pandemic and Vaccination. The concepts of his Virology study are interwoven with issues in In vitro, Antibody and Immune system. Randy A. Albrecht regularly ties together related areas like Adverse effect in his Virus studies.
His Influenza A virus study is concerned with the field of Immunology as a whole. His Vaccination research is multidisciplinary, incorporating elements of Reactogenicity, Immunogenicity, Epidemiology and Antigenic drift. The study incorporates disciplines such as Ex vivo, Transcriptome, Host and Interferon in addition to Chemokine.
His primary scientific interests are in Pandemic, Coronavirus, Disease, Chemokine and Virus. Randy A. Albrecht integrates many fields, such as Pandemic and engineering, in his works. The various areas that Randy A. Albrecht examines in his Disease study include Coagulopathy and Endothelial dysfunction.
The Chemokine study combines topics in areas such as Cell, In vitro, Influenza A virus, Host and In vivo. His Virus study contributes to a more complete understanding of Virology. His research is interdisciplinary, bridging the disciplines of Ex vivo and Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo;Benjamin E. Nilsson-Payant;Wen Chun Liu;Skyler Uhl.
Cell (2020)
Programming the magnitude and persistence of antibody responses with innate immunity.
Sudhir Pai Kasturi;Ioanna Skountzou;Randy A. Albrecht;Dimitrios Koutsonanos.
Nature (2011)
Influenza A Virus NS1 Targets the Ubiquitin Ligase TRIM25 to Evade Recognition by the Host Viral RNA Sensor RIG-I
Michaela Ulrike Gack;Randy Allen Albrecht;Tomohiko Urano;Tomohiko Urano;Kyung-Soo Inn;Kyung-Soo Inn.
Cell Host & Microbe (2009)
Meta- and Orthogonal Integration of Influenza “OMICs” Data Defines a Role for UBR4 in Virus Budding
Shashank Tripathi;Marie O. Pohl;Yingyao Zhou;Ariel Rodriguez-Frandsen.
Cell Host & Microbe (2015)
Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes
Monique Gannagé;Dorothee Dormann;Randy Albrecht;Jörn Dengjel.
Cell Host & Microbe (2009)
Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination.
Salah Eddine Bentebibel;Santiago Lopez;Gerlinde Obermoser;Nathalie Schmitt.
Science Translational Medicine (2013)
Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus
Carole R. Baskin;Helle Bielefeldt-Ohmann;Terrence M. Tumpey;Patrick J. Sabourin.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
Michael J. Ciancanelli;Sarah X.L. Huang;Priya Luthra;Hannah Garner.
Science (2015)
Suppression of the antiviral response by an influenza histone mimic
Ivan Marazzi;Jessica S. Y. Ho;Jaehoon Kim;Balaji Manicassamy.
Nature (2012)
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
John Steel;Anice C. Lowen;Lindomar Pena;Matthew Angel.
Journal of Virology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Harvard University
Discovery Institute
University of Washington
Centers for Disease Control and Prevention
The University of Texas at Austin
Polytechnic University of Milan
Georgia Institute of Technology
The University of Texas at Austin
University of Chicago
Sandia National Laboratories
Argonne National Laboratory
University of Turin
University of Jyväskylä
University of Florence
AgResearch
Oklahoma Medical Research Foundation
University of Alabama at Birmingham
Seoul National University Hospital
University of London
University of Calabria